Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
2016;94(3):e170-176
Rather than open access or blanket exclusions, leading employers are tying GLP-1 coverage to objective clinical criteria: BMI thresholds, documented comorbidities, and biometric screening data
3 In the largest phase 3a trial, STEP 1, results showed that patients taking Wegovy achieved a mean weight loss of 15 per cent (15 kg) sustained over 68 weeks
Int J Clin Nutr Diet
Kokkinos A, le Roux CW, Alexiadou K, et al
US$ 21.69
US$ 21.83
US$ 26.81
US$ 26.86
